The global heparin market size is expected to reach USD 7.55 Billion in 2028 at a CAGR of 1.4% during the forecast period, according to the latest report by Reports and Data. Rising demand for heparin due to the high prevalence of chronic conditions such as last-stage renal disease, atrial fibrillation, and cardiovascular diseases, an increasing number of surgical procedures performed across the globe, and extensive RD activities to explore other clinical and therapeutic roles of heparin are key factors expected to drive market revenue growth over the forecast period. In addition, heparin is used for various off-label indications in hospitals and for treatment and prevention of venous thromboembolism events in post-surgical patients, and this is another factor expected to contribute to the revenue growth of the market going ahead.
Heparin is a widely used anticoagulant that significantly reduces clotting risks and thromboembolism events after major surgical interventions. Heparin is a naturally occurring polysaccharide belonging to the family of glycosaminoglycans that are primarily present in mast cells. Heparin exerts anticoagulant properties by binding to antithrombin and enhancing the subsequent inhibitory effect of antithrombin on thrombin and activated factor X. The currently available heparin is mostly obtained from animal tissue. However, due to growing concerns regarding animal safety, several approaches for bioengineering heparin such as microbial production and chemoenzymatic modification among others are increasingly being researched on. Major players are also focusing on RD for its potential clinical and therapeutic applications such as anti-inflammatory and anti-tumor activities as well as its role in the prevention of infectious diseases, besides its use as an anticoagulant. Heparin has antineoplastic properties along with anticoagulant properties, and this is expected to result in increasing research activities to explore the potential of heparin for treating various other conditions. This, in turn, is expected to significantly contribute to market revenue growth going ahead.
Venous thromboembolism prophylaxis with anticoagulant therapy is often used for cancer patients who are hospitalized or undergoing chemotherapy. However, possible risks of bleeding with the use of heparin and its derivatives have limited its use in the management of cancer patients in other therapeutic settings, and this could hamper the market growth to a certain extent over the forecast period.
In-depth Study of the Competitive Landscape:
The global Heparin market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers acquisitions, joint ventures, collaborations, partnerships, and agreements, to build on their market presence.
Top companies profiled in the report include:
Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Sanofi SA, B. Braun Melsungen AG, GlaxoSmithKline PLC, LEO Pharma A/S, Aspen Holdings, Fresenius SE Co. KGaA, and Viatris Inc.
Key Market Regions Covered in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Product Type Outlook (Revenue, USD Billion; 2018-2028)
- Unfractionated Heparin
- Low Molecular Weight Heparin
- Ultra-low Molecular Weight Heparin
Route of Administration (Revenue, USD Billion; 2018-2028)
- Subcutaneous
- Intravenous
Application Outlook (Revenue, USD Billion; 2018-2028)
- Coronary Artery Disease
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Others
Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Heparin market over the forecast period?
- What are the major factors driving the growth of the Global Heparin Market?
- What are the key challenges impacting the global Heparin market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4154
Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
